Edward Raymond Jones is Director of Cytosorbents Corp. Currently has a direct ownership of 88,834 shares of CTSO, which is worth approximately $80,838. The most recent transaction as insider was on Dec 13, 2023, when has been sold 7,519 shares (Common Stock) at a price of $1.33 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.8K
0% 3M change
9.25% 12M change
Total Value Held $80,838

Edward Raymond Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2023
BUY
Open market or private purchase
$10,000 $1.33 p/Share
7,519 Added 7.8%
88,834 Common Stock
May 16 2022
BUY
Open market or private purchase
$3,754 $2.24 p/Share
1,676 Added 2.02%
81,315 Common Stock
Dec 09 2021
SELL
Payment of exercise price or tax liability
$16,500 $5.22 p/Share
3,161 Reduced 3.82%
79,639 Common Stock
Dec 09 2021
BUY
Exercise of conversion of derivative security
$16,480 $4.12 p/Share
4,000 Added 4.61%
82,800 Common Stock
ERJ

Edward Raymond Jones

Director
Princeton, NJ

Track Institutional and Insider Activities on CTSO

Follow Cytosorbents Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTSO shares.

Notify only if

Insider Trading

Get notified when an Cytosorbents Corp insider buys or sells CTSO shares.

Notify only if

News

Receive news related to Cytosorbents Corp

Track Activities on CTSO